期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

耐药性卵巢上皮性癌治疗进展 被引量：2

原文传递
导出
摘要 卵巢上皮性癌（卵巢癌）是常见的妇女生殖系统恶性肿瘤,其病死率居妇科恶性肿瘤之首.随着手术治疗的进步及化疗药物的开发,卵巢癌的治疗效果有了很大改善,但患者的5年生存率仍然很低.其重要原因就是化疗耐药性的产生.据报道,在首次化疗中,化疗反应率大约是80%,而当卵巢癌复发时,化疗反应率降低到20%[1].因此,逆转并治疗耐药性卵巢癌在提高卵巢癌治疗效果、改善患者预后方面具有极其重要的意义.
作者 张果 李巍 崔恒
机构地区 北京大学人民医院妇科肿瘤中心
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2006年第9期644-647,共4页 Chinese Journal of Obstetrics and Gynecology
关键词 卵巢上皮性癌 化疗耐药性 手术治疗 耐药性卵巢癌 生殖系统恶性肿瘤 妇科恶性肿瘤 化疗药物 治疗效果
分类号 R737.31 [医药卫生—肿瘤]
  • 相关文献

参考文献24

  • 1Markman M,Bookman MA.Second-line treatment of ovarian cancer.Oncologist,2000,5:26-35.
  • 2Kavanagh JJ,Gershenson DM,Choi H,et al.Multi-institutional phase 2 study of TLK286 (TELCYTA,a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer.Int J Gynecol Cancer,2005,15:593-600.
  • 3Vasilevskaya IA,O' Dwyer PJ.17-Allylamino-17-demethoxygel-danamycin overcomes TRAIL resistance in colon cancer cell lines.Biochem Pharmacol,2005,70:580-589.
  • 4Goetz MP,Toft D,Reid J,et al.Phase Ⅰ trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer.J Clin Oncol,2005,23:1078-1087.
  • 5Fujita T,Washio K,Takabatake D,et al.Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance.Int J Cancer,2005,117:670-682.
  • 6Minko T,Dharap SS,Fabbricatore AT,et al.Enhancing the efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular defense.Cancer Detect Prey,2003,27:193-202.
  • 7Monk BJ,Han E,Josephs-Cowan CA,et al.Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer.Gynecol Oncol,2006,102:140-144.
  • 8Cohn DE,Valmadre S,Resnick KE,et al.Bevacizumab and weekly taxane chemotherapy demonstrates activity in refractory ovarian cancer.Gynecol Oncol,2006,102:134-139.
  • 9Weng DE,Usman N.Angiozyme:a novel angiogenesis inhibitor.Curr Oncol Rep,2001,3:141-146.
  • 10Baird RD,Kaye SB.Drug resistance reversal-are we getting closer.Eur J Cancer,2003,39:2450-2461.

同被引文献28

  • 1Rittling SR, Chambers AF. Role of osteopontin in tumor progression [J]. BrJCancer, 2004, 90 (10): 1877-1881.
  • 2Mattem J, Koomagi R, Volm MS. Association of vascular endothelial growth factor expression with int ratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma [J]. BrJ Cancer, 1996, 73 (7): 931-934.
  • 3Senger DR, Winh DF, Hynes RO. Trausfonned mammalian ceuesecrete specific proteins and phosphoproteins[J]. Cell, 1979, 16 (4): 885-893.
  • 4Brown LF, Papadopoulos SA, expression and distribution in Berse B, et al. Osteopontin human carcinomas [J].AmPathol, 1994, 145 (4): 610- 623.
  • 5SulzbacherI, Bimer P, Trieb K, et al. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors [J]. Virchows Arch, 2002, 441 (4): 345-349.
  • 6Coppola D, Szabo M, Boulware D, et al. Correlation of osteopontinprotein expression and pathological stage across a wide variety oftumor histologies [J]. Clin Cancer Res, 2004, 10 (1): 184-190.
  • 7Rosen DG, Wang L, Atkinson JN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer [J]. Gynecol Oncol, 2005, 99 (2): 267-277.
  • 8Maki M, Hirota S, Kaneko Y, et al. Expression of osteopont in messenger RNA by macrophages in ovarian serous papillary eystadenoearcinoma: a possible association with calcification of psammom a bodies [J]. Pathol Int, 2000, 50 (7): 531-535.
  • 9Ito T, Hashimoto Y, Tanaka E, et al. An inducible short- hairpinRNA vector against osteopontin reduces metastatic potential of human esophageal sqamous cell carcinoma in virtro and in vivo [J]. Clin Cancer Res, 2006, 12 (4) : 1308-1316.
  • 10Dinh P, Harnett P, Piccart-Gebhart MJ, et al. New therapies forovarian cancer: cytotoxics and molecularly targeted agents [ J ].Crit Rev Oncol Hematol, 2008 ,67(2) : 103-112.

引证文献2

二级引证文献8

中华妇产科杂志
2006年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部